{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:56:39Z","timestamp":1767963399986,"version":"3.49.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0051600","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T22:01:35Z","timestamp":1362780095000},"page":"e51600","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Multiple Sites of the Cleavage of 21- and 25-Mer Encephalytogenic Oligopeptides Corresponding to Human Myelin Basic Protein (MBP) by Specific Anti-MBP Antibodies from Patients with Systemic Lupus Erythematosus"],"prefix":"10.1371","volume":"8","author":[{"given":"Anna M.","family":"Timofeeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel S.","family":"Dmitrenok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmila P.","family":"Konenkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina N.","family":"Buneva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgy A.","family":"Nevinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Keinan E ed (2005) Catalytic antibodies: Weinheim, Germany: Wiley-VCH Verlag GmbH and Co. KgaA. p. 1\u2013586","DOI":"10.1002\/3527603662.ch1"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-1759(02)00234-X","article-title":"Human catalytic RNA- and DNA-hydrolyzing antibodies","volume":"269","author":"GA Nevinsky","year":"2002","journal-title":"J Immunol Methods"},{"key":"ref3","unstructured":"Nevinsky GA, Favorova OO, Buneva VN (2002) Natural Catalytic Antibodies-New Characters in the Protein Repertoire. In: Golemis E editor. Protein-protein interactions; a molecular cloning manual. New York: Cold Spring Harbor Lab. Press, pp. 1\u2013523."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1582-4934.2003.tb00227.x","article-title":"Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies","volume":"7","author":"GA Nevinsky","year":"2003","journal-title":"J Cell Mol Med"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Nevinsky GA, Buneva VN (2005) Natural catalytic antibodies-abzymes. In: Keinan E editor. Catalytic antibodies. Weinheim, Germany: VCH-Wiley press. pp. 503\u2013567.","DOI":"10.1002\/3527603662.ch19"},{"key":"ref6","first-page":"1203","article-title":"Natural catalytic antibodies in norm, autoimmune, viral, and bacterial diseases","volume":"10","author":"GA Nevinsky","year":"2010"},{"key":"ref7","unstructured":"Nevinsky GA (2010) Natural catalytic antibodies in norm and in autoimmune diseases. In: Brenner KJ editor. Autoimmune Diseases: Symptoms, Diagnosis and Treatment. USA: Nova Science Publishers, Inc. pp. 1\u2013107."},{"key":"ref8","unstructured":"Nevinsky GA (2011) Natural catalytic antibodies in norm and in HIV-infected patients. In: Fyson Hanania Kasenga editor. Understanding HIV\/AIDS Management and Care\u2013Pandemic Approaches the 21st Century. InTech. pp. 151\u2013192."},{"key":"ref9","first-page":"960","article-title":"Affinity and catalytic heterogeneity and metal-dependence of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with systemic lupus erythematosus","volume":"24","author":"AM Bezuglova","year":"2011"},{"key":"ref10","first-page":"545","article-title":"DNA-hydrolyzing activity of IgG antibodies from the sera of patients with tick-borne encephalitis","volume":"92","author":"TA Parkhomenko","year":"2010"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1011064007686","article-title":"Neuroimmunology of multiple sclerosis","volume":"21","author":"KC O'Connor","year":"2001","journal-title":"J Clin Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W","article-title":"The role of B cells and autoantibodies in multiple sclerosis","volume":"47","author":"JJ Archelos","year":"2000","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrn784","article-title":"New concepts in the immunopathogenesis of multiple sclerosis","volume":"3","author":"B Hemmer","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"ref14","unstructured":"Hhachn BCh (1996) Systemic lipus erythematosus. In: Braunvald EE, Isselbakher KD, Petersdorf RG, Wilson DD, Martin DB, Fauchi AS, editors. Moscow: Internal diseases, Medicine. pp. 407\u2013419."},{"key":"ref15","first-page":"850","article-title":"Immune response to DNA in systemic lupus erythematosus","volume":"3","author":"D Pisetsky","year":"2001","journal-title":"Isr Med Ass J"},{"key":"ref16","unstructured":"Poser CM (1984) The diagnosis of multiple sclerosis, NY: Thieme-Stratton; pp. 3\u201313."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1073\/pnas.98.4.1793","article-title":"Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis","volume":"98","author":"RA Williamson","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.1585181","article-title":"DNA hydrolyzing autoantibodies","volume":"256","author":"AM Shuster","year":"1992","journal-title":"Science"},{"key":"ref19","first-page":"460","article-title":"Catalytic heterogeneity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus","volume":"6","author":"OA Andrievskaya","year":"2000","journal-title":"Med Sci Monit"},{"key":"ref20","first-page":"460","article-title":"Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from from sera of patients with lupus erythematosus","volume":"6","author":"OA Andrievskaya","year":"2000","journal-title":"Med Sci Monit"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1008826909441","article-title":"Antibodies with amylolytic activity","volume":"6","author":"AN Savel'ev","year":"1999","journal-title":"Prot Pept Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4052\/tigg.16.17","article-title":"Human antibodies with amylolytic activity","volume":"16","author":"AN Savel'ev","year":"2004","journal-title":"Trends in Glycoscience and Glycotechnology"},{"key":"ref23","first-page":"1239","article-title":"Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA","volume":"63","author":"AG Baranovskii","year":"1998","journal-title":"Biochemistry (Moscow)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-2478(01)00185-7","article-title":"Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis","volume":"76","author":"AG Baranovskii","year":"2001","journal-title":"Immunol Let"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0165-2478(03)00042-7","article-title":"Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis","volume":"86","author":"AN Saveliev","year":"2003","journal-title":"Immunol Lett"},{"key":"ref26","first-page":"45","article-title":"Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases","volume":"75","author":"AV Kozyr","year":"1998"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1582-4934.2004.tb00325.x","article-title":"Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis","volume":"8","author":"DI Polosukhina","year":"2004","journal-title":"J Cell Mol Med"},{"key":"ref28","first-page":"BR266","article-title":"Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis","volume":"11","author":"DI Polosukhina","year":"2005","journal-title":"Med Sci Monit"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.imlet.2005.10.018","article-title":"Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis","volume":"103","author":"DI Polosukhina","year":"2006","journal-title":"Immunol Lett"},{"key":"ref30","first-page":"699","article-title":"Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis","volume":"14","author":"GA Legostaeva","year":"2010"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1073\/pnas.0509849103","article-title":"Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen","volume":"103","author":"NA Ponomarenko","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.4049\/jimmunol.159.3.1530","article-title":"Chacterization of thyroglobulin-directed and polyreactive catalytic antibodies in autoimmune disease","volume":"159","author":"S Paul","year":"1997","journal-title":"J Immunol"},{"key":"ref33","first-page":"601","article-title":"Antibodies to HIV integrase catalyze site-specific degradation of their antigen","volume":"23","author":"ES Odintsova","year":"2011"},{"key":"ref34","first-page":"193","article-title":"Anti-integrase abzymes from the sera of HIV-infected patients specifically hydrolyze integrase but nonspecifically cleave short oligopeptides","volume":"25","author":"ES Odintsova","year":"2012"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.4049\/jimmunol.154.7.3328","article-title":"Catalytic activity of anti-thyroglobulin antibodies","volume":"154","author":"L Li","year":"1995","journal-title":"J Immunol"},{"key":"ref36","first-page":"32389","article-title":"Molecular cloning of a proteolytic antibody light chain","volume":"269","author":"QS Gao","year":"1994"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1021\/bi992588w","article-title":"Monoclonal antibody light chain with prothrombinase activity","volume":"39","author":"P Thiagarajan","year":"2000","journal-title":"Biochemistry"},{"key":"ref38","first-page":"15257","article-title":"Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment","volume":"270","author":"S Paul","year":"1995"},{"key":"ref39","first-page":"727","article-title":"Multiple sclerosis: molecular and cellular mechanisms","volume":"29","author":"AN Boiko","year":"1995"},{"key":"ref40","unstructured":"Fersht A (1985) Enzyme Structure and Mechanism. 2<sup>nd<\/sup> ed., N.Y.: W. H. Freeman Co."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0051600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T01:19:48Z","timestamp":1688087988000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0051600"}},"subtitle":[],"editor":[{"given":"Vladimir N.","family":"Uversky","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,8]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0051600","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,8]]}}}